Ivan Zlatev

3.0k total citations
46 papers, 1.7k citations indexed

About

Ivan Zlatev is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Infectious Diseases. According to data from OpenAlex, Ivan Zlatev has authored 46 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 9 papers in Cardiology and Cardiovascular Medicine and 5 papers in Infectious Diseases. Recurrent topics in Ivan Zlatev's work include RNA Interference and Gene Delivery (22 papers), Advanced biosensing and bioanalysis techniques (16 papers) and DNA and Nucleic Acid Chemistry (15 papers). Ivan Zlatev is often cited by papers focused on RNA Interference and Gene Delivery (22 papers), Advanced biosensing and bioanalysis techniques (16 papers) and DNA and Nucleic Acid Chemistry (15 papers). Ivan Zlatev collaborates with scholars based in United States, Netherlands and France. Ivan Zlatev's co-authors include Muthiah Manoharan, Kallanthottathil G. Rajeev, Martin A. Maier, Ravi Sachidanandam, Jasmine T. Perez, Benjamin R. tenOever, Jean‐Jacques Vasseur, Martin Egli, Mark K. Schlegel and F. Morvan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Nucleic Acids Research.

In The Last Decade

Ivan Zlatev

44 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ivan Zlatev United States 21 1.3k 211 178 174 166 46 1.7k
Ragunath Singaravelu Canada 21 668 0.5× 425 2.0× 76 0.4× 49 0.3× 229 1.4× 33 1.2k
Peter J. Welch United States 18 1.1k 0.9× 144 0.7× 32 0.2× 61 0.4× 126 0.8× 24 1.7k
Corinne Rommens France 14 640 0.5× 74 0.4× 30 0.2× 106 0.6× 121 0.7× 28 1.0k
Dawn L. Hall United States 14 508 0.4× 51 0.2× 279 1.6× 43 0.2× 234 1.4× 16 930
Joseph Marakovits United States 10 657 0.5× 38 0.2× 177 1.0× 202 1.2× 91 0.5× 12 1.0k
Qian Chai China 18 527 0.4× 57 0.3× 89 0.5× 28 0.2× 103 0.6× 44 1.6k
Hao Shao United States 21 909 0.7× 41 0.2× 82 0.5× 38 0.2× 57 0.3× 47 1.3k
Ming‐Yi Ho Taiwan 18 541 0.4× 101 0.5× 76 0.4× 26 0.1× 158 1.0× 28 976
Masaharu Hazawa Japan 22 915 0.7× 199 0.9× 115 0.6× 17 0.1× 68 0.4× 64 1.3k
Joke Regts Netherlands 22 694 0.6× 51 0.2× 126 0.7× 25 0.1× 293 1.8× 36 1.4k

Countries citing papers authored by Ivan Zlatev

Since Specialization
Citations

This map shows the geographic impact of Ivan Zlatev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivan Zlatev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivan Zlatev more than expected).

Fields of papers citing papers by Ivan Zlatev

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ivan Zlatev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivan Zlatev. The network helps show where Ivan Zlatev may publish in the future.

Co-authorship network of co-authors of Ivan Zlatev

This figure shows the co-authorship network connecting the top 25 collaborators of Ivan Zlatev. A scholar is included among the top collaborators of Ivan Zlatev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ivan Zlatev. Ivan Zlatev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Foster, Don, et al.. (2025). Kidney Arteriolar Responses to Liver‐Targeted Small Interference RNA Targeting Angiotensinogen in Diabetic Rats: Comparison With Other Renin‐Angiotensin System Blockers. Journal of the American Heart Association. 14(2). e038326–e038326. 2 indexed citations
2.
Aluri, Krishna, Dhrubajyoti Datta, Nate Taneja, et al.. (2024). Single-Stranded Hairpin Loop RNAs (loopmeRNAs) Potently Induce Gene Silencing through the RNA Interference Pathway. Journal of the American Chemical Society. 1 indexed citations
3.
Farley, Jonathan E., Jeffery D. Haines, Tuyen Nguyen, et al.. (2023). An Investigational RNAi Therapeutic for Tau Lowering. Alzheimer s & Dementia. 19(S21). 1 indexed citations
4.
Datta, Dhrubajyoti, et al.. (2022). A Chemical Approach to Introduce 2,6-Diaminopurine and 2-Aminoadenine Conjugates into Oligonucleotides without Need for Protecting Groups. Organic Letters. 24(33). 6111–6116. 7 indexed citations
5.
6.
Bovée, Dominique M., Liwei Ren, Estrellita Uijl, et al.. (2021). Renoprotective Effects of Small Interfering RNA Targeting Liver Angiotensinogen in Experimental Chronic Kidney Disease. Hypertension. 77(5). 1600–1612. 22 indexed citations
7.
Taneja, Nate, Jennifer L. S. Willoughby, Christopher R. Brown, et al.. (2021). Chirality matters: stereo-defined phosphorothioate linkages at the termini of small interfering RNAs improve pharmacology in vivo. Nucleic Acids Research. 50(3). 1221–1240. 55 indexed citations
8.
Podbevšek, Peter, Swati Gupta, Anna Bisbe, et al.. (2021). Small circular interfering RNAs (sciRNAs) as a potent therapeutic platform for gene-silencing. Nucleic Acids Research. 49(18). 10250–10264. 17 indexed citations
9.
10.
Mikami, Atsushi, Shigeo Matsuda, Alexander V. Kel’in, et al.. (2020). Synthesis, chirality-dependent conformational and biological properties of siRNAs containing 5′-(R)- and 5′-(S)-C-methyl-guanosine. Nucleic Acids Research. 48(18). 10101–10124. 19 indexed citations
11.
Uijl, Estrellita, Katrina M. Mirabito Colafella, Yuan Sun, et al.. (2019). Strong and Sustained Antihypertensive Effect of Small Interfering RNA Targeting Liver Angiotensinogen. Hypertension. 73(6). 1249–1257. 88 indexed citations
12.
Harp, Joel M., Dale C. Guenther, Anna Bisbe, et al.. (2018). Structural basis for the synergy of 4′- and 2′-modifications on siRNA nuclease resistance, thermal stability and RNAi activity. Nucleic Acids Research. 46(16). 8090–8104. 37 indexed citations
13.
Zlatev, Ivan, Adam Castoreno, Christopher R. Brown, et al.. (2018). Reversal of siRNA-mediated gene silencing in vivo. Nature Biotechnology. 36(6). 509–511. 69 indexed citations
14.
Janas, Maja M., Mark K. Schlegel, Carole E. Harbison, et al.. (2018). Selection of GalNAc-conjugated siRNAs with limited off-target-driven rat hepatotoxicity. Nature Communications. 9(1). 723–723. 200 indexed citations
15.
Schlegel, Mark K., Donald J. Foster, Alexander V. Kel’in, et al.. (2017). Chirality Dependent Potency Enhancement and Structural Impact of Glycol Nucleic Acid Modification on siRNA. Journal of the American Chemical Society. 139(25). 8537–8546. 62 indexed citations
16.
Iwamoto, Naoki, David C. Butler, Nenad Svrzikapa, et al.. (2017). Control of phosphorothioate stereochemistry substantially increases the efficacy of antisense oligonucleotides. Nature Biotechnology. 35(9). 845–851. 263 indexed citations
17.
Hao, Wei, J.A. Wojdyla, Rong Zhao, et al.. (2017). Crystal structure of Middle East respiratory syndrome coronavirus helicase. PLoS Pathogens. 13(6). e1006474–e1006474. 97 indexed citations
18.
Zhang, Kaixin, Yuen Yi C. Tam, Ying K. Tam, et al.. (2016). A Glu-urea-Lys Ligand-conjugated Lipid Nanoparticle/siRNA System Inhibits Androgen Receptor Expression In Vivo. Molecular Therapy — Nucleic Acids. 5. e348–e348. 49 indexed citations
19.
Zlatev, Ivan, Jeremy G. Lackey, Ligang Zhang, et al.. (2012). Automated parallel synthesis of 5′-triphosphate oligonucleotides and preparation of chemically modified 5′-triphosphate small interfering RNA. Bioorganic & Medicinal Chemistry. 21(3). 722–732. 16 indexed citations
20.
Perez, Jasmine T., Andrew Varble, Ravi Sachidanandam, et al.. (2010). Influenza A virus-generated small RNAs regulate the switch from transcription to replication. Proceedings of the National Academy of Sciences. 107(25). 11525–11530. 161 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ragunath Singaravelu Breakdown of academic impact, for papers by Peter J. Welch Breakdown of academic impact, for papers by Corinne Rommens Breakdown of academic impact, for papers by Dawn L. Hall Breakdown of academic impact, for papers by Joseph Marakovits Breakdown of academic impact, for papers by Qian Chai Breakdown of academic impact, for papers by Hao Shao Breakdown of academic impact, for papers by Ming‐Yi Ho Breakdown of academic impact, for papers by Masaharu Hazawa Breakdown of academic impact, for papers by Joke Regts
Rankless by CCL
2026